Kenneth Hensley
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: University of Toledo Medical Center (2010–2015); National Institutes of Health (2006); NewYork–Presbyterian Hospital (2006); University of Wisconsin–Madison (2014); University of Kentucky (1993–2007); Cornell University (2006); Konkuk University (2006); New York Hospital Queens (2006); Oklahoma Medical Research Foundation (1996–2010); Center for Neurosciences (2004); Membrane Technology & Research (United States) (1996–1999); National Institute on Aging (2006); VA Greater Los Angeles Healthcare System (2013); OU Health (2007); University of Oklahoma Health Sciences Center (2000–2006); University of Oklahoma (2007); University of Toledo (2009–2018)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Kenneth Hensley's research investigates the intersection of sulfur redox chemistry, cellular signal transduction, and proteostasis, with a focus on understanding and treating neurodegenerative diseases. His work has explored the therapeutic potential of specific compounds, such as lanthionine ketimine ethyl ester, in animal models. For instance, he has studied its capacity to accelerate remyelination in a mouse model of multiple sclerosis and its effects on the α-synucleinopathy mouse model. Additionally, his research has examined the inhibitory effects of phytochemicals, like hypoxoside derived from H. rooperii, on nitric oxide production in murine macrophages, a process relevant to immune response and inflammation.
Hensley is recognized as a highly cited researcher, with a significant publication record and citation count. His scholarly output includes 169 publications, garnering over 12,000 citations, and he holds an h-index of 58. He has collaborated with researchers such as T.M. do Nascimento Garcia and William Farrell at the University of Arkansas – Fort Smith on shared publications. His recent publications in 2021 and 2022 indicate ongoing activity in his research areas.
Metrics
- h-index: 58
- Publications: 169
- Citations: 12,117
Selected Publications
-
Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis (2022)
-
Effects of Lanthionine Ketimine-5-Ethyl Ester on the α-Synucleinopathy Mouse Model (2022)
-
At the intersection of sulfur redox chemistry, cellular signal transduction and proteostasis: A useful perspective from which to understand and treat neurodegeneration (2021)
-
Stable knockout of lanthionine synthase C-like protein-1 (LanCL1) from HeLa cells indicates a role for LanCL1 in redox regulation of deubiquitinating enzymes (2020)
-
Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation (2020)
-
An overview of sulfur-containing compounds originating from natural metabolites: Lanthionine ketimine and its analogues (2019)
-
Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis (2019)
-
Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinson’s model mice (2018)
-
Development and applications of solid-phase extraction and liquid chromatography-mass spectrometry methods for quantification of microcystins in urine, plasma, and serum (2018)
-
Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh‐pressure liquid chromatography/tandem mass spectrometry (2018)
-
Multiple-step, one-pot synthesis of 2-substituted-3-phosphono-1-thia-4-aza-2-cyclohexene-5-carboxylates and their corresponding ethyl esters (2018)
-
Lanthionine ketimine-5-ethyl ester provides neuroprotection in a zebrafish model of okadaic acid-induced Alzheimer's disease (2018)
-
Neuroprotective and neurotrophic effects of Lanthionine Ketimine Ester (2017)
-
Collapsin response mediator protein 2: high-resolution crystal structure sheds light on small-molecule binding, post-translational modifications, and conformational flexibility (2017)
Collaboration Network
Top Collaborators
- At the intersection of sulfur redox chemistry, cellular signal transduction and proteostasis: A useful perspective from which to understand and treat neurodegeneration
- At the intersection of sulfur redox chemistry, cellular signal transduction and proteostasis: A useful perspective from which to understand and treat neurodegeneration
- At the intersection of sulfur redox chemistry, cellular signal transduction and proteostasis: A useful perspective from which to understand and treat neurodegeneration
- At the intersection of sulfur redox chemistry, cellular signal transduction and proteostasis: A useful perspective from which to understand and treat neurodegeneration
- At the intersection of sulfur redox chemistry, cellular signal transduction and proteostasis: A useful perspective from which to understand and treat neurodegeneration
- Effects of Lanthionine Ketimine-5-Ethyl Ester on the α-Synucleinopathy Mouse Model
- Effects of Lanthionine Ketimine-5-Ethyl Ester on the α-Synucleinopathy Mouse Model
- Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
- Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
- Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
- Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
- Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
- Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
- Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
- Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
Similar Researchers
Based on overlapping research topics